University of Hertfordshire

  • Syed Shahzad Hasan
  • Chia Siang How
  • Dalia M Dawoud
  • Omneya Mohamed
  • Darrin Baines
  • Zaheer-Ud-Din Babar
View graph of relations
Original languageEnglish
JournalValue in Health Regional Issues
Journal publication date22 Aug 2018
Publication statusAccepted/In press - 22 Aug 2018

Abstract

Medicine price affects affordability and access to medicines directly particularly in countries where a major portion of pharmaceutical spending is through out-of-pocket payment, such as in the Asia Pacific region. We have undertaken a detailed appraisal of the pharmaceutical policy reforms to regulate drug prices in three developed (Australia, New Zealand and South Korea) and three emerging (China, India and Malaysia) economies of Asia-Pacific region. Despite continuous effort by the authorities in adopting a wide range of reformatory pharmaceutical pricing policies to ensure affordability of medicines, these policies may not be optimal where drug prices were not lowered as expected (e.g. in Korea). In contrary, considerable price reductions of various pharmaceuticals have been observed in New Zealand and India owing to the reform in pharmaceutical pricing policy. This review of pharmaceutical pricing reforms reinforces the need for constant monitoring by policymakers in the Asia-Pacific countries to regulate drug prices and to undertake reform in pharmaceutical pricing policies when necessary to ensure affordability and access to medicines.

ID: 15215728